Takeda Commits $32 Million to Enhance Global Health Systems

Takeda, a leader in health innovation, has pledged JPY 4.6 billion (approximately USD 32 million) to five new Global Corporate Social Responsibility (CSR) partners. This initiative aims to bolster health systems in low- and middle-income countries, addressing systemic disparities and empowering local communities. By 2030, Takeda’s efforts are expected to reach 27 million people across 93 countries, elevating total contributions since 2016 to over JPY 28.8 billion (about USD 199.1 million).

The new partnerships, chosen by over 22,000 Takeda employees globally, underscore the company’s collaborative approach to corporate giving. “Since our founding in 1781, Takeda has prioritized patients and society in our decisions. Our Global CSR Programme reflects our commitment to tackling health challenges worldwide,” said Takako Ohyabu, Chief Global Corporate Affairs and Sustainability Officer.

Key commitments for FY2024 include:

• Population Services International (PSI): JPY 1,007 million to expand vaccine access in Ethiopia, Kenya, and Nigeria through pharmacy-based immunization.
• Bulungula Incubator: JPY 310 million to integrate community-driven healthcare in South Africa’s remote areas.
• Reach Out Cameroon: JPY 1,169 million to improve care for women and girls in conflict-affected regions.
• Seed Global Health: JPY 895 million to train health professionals in Malawi, Sierra Leone, Uganda, and Zambia.
• VillageReach: JPY 1,259 million to strengthen health systems in several African nations for rapid outbreak response.

The initiatives aim to create scalable, equitable healthcare solutions, making a significant impact on vulnerable populations. “Vaccines save lives, and this partnership will empower pharmacies to enhance vaccination rates,” stated Karl Hofmann, CEO of PSI. Each new collaboration is designed to foster resilience and innovation in healthcare delivery, reflecting Takeda’s long-term commitment to improving global health.